Medicines Optimization Prior to Discharge in Patients Admitted to Hospital with Heart Failure
Joseph J. Cuthbert(University of Hull), Andrew L. Clark(University of Hull), John G.F. Cleland(Imperial College London), Jeanne Bulemfu(Castle Hill Hospital), Karen Dobbs(Castle Hill Hospital), Pierpaolo Pellicori(Glasgow Royal Infirmary), Ioanna Sokoreli(Philips (Netherlands)), Oliver Brown(University of Leeds), Syed Jamil Hasan Kazmi(University of Hull), Steffan C. Pauws(NXP (Netherlands)), Jarno Riistama(Philips (Netherlands))
Cited by 4
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
|European Heart Journal|2017|643
Declining Risk of Sudden Death in Heart Failure
|New England Journal of Medicine|2017|500